That doesn't necessarily mean they don't seem to be contemplating it. A number of breakthrough therapy designations happen to be granted for psilocybin while in the treatment of resistant depression—that is, depression that does not respond to at the least two different types of antidepressants—and a broader approval can be around the horizon.T